查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球气雾剂贴片市场
市场调查报告书
商品编码
1319140

2023-2030 年全球气雾剂贴片市场

Global Vacular Patches Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概述

全球血管系统市场规模在 2022 年达到 7 亿美元，预计到 2030 年将达到 12 亿美元，2023-2030 年的复合年增长率为 7.6%。动脉瘤、动脉狭窄和不必要的血栓等疾病的流行等因素推动了预测期内的市场规模。由于老龄人口数量的增加，北美地区的市场规模也在不断扩大，其主要竞争对手包括泰尔茂公司、C R Bard 公司、博朗梅尔松根公司等。

血管贴片用于外周血管重建、表面线支撑和其他修复。血管贴片由聚酯聚氨酯制成。补片中使用的弹性材料有助于减少缝合孔出血。

市场动态

慢性静脉功能不全的增加将推动市场增长

推动血管贴片市场发展的主要因素是慢性静脉功能不全病例数量的增加。许多人患有慢性静脉功能不全，这导致了血管手术，从而推动了市场的增长。慢性静脉功能不全的增加将推动市场增长，例如，发表在《Stats Pearls》上的一篇文章指出，慢性静脉功能不全（CVI）通常指下肢水肿、皮肤营养性改变以及继发于静脉高压的不适。慢性静脉功能不全是一种常见疾病。

与慢性静脉功能不全有关的残疾会导致生活质量下降和工作效率降低。大多数情况下，病因是瓣膜功能不全。每年约有 15 万新患者被诊断为慢性静脉功能不全，用于治疗这些患者的费用将近 5 亿美元。因此，疾病的增加将推动市场增长。

主要企业的关键战略将推动市场增长

主要企业关键战略的兴起将主导市场增长。例如，2022 年 5 月 19 日，总部位于爱尔兰的血管闭合设备公司 Vivasure 通过一系列投资筹集了约 2500 万美元，用于推进其可吸收贴片式经皮血管闭合技术的临床开发和监管审批。PerQseal "技术在血管内和心血管手术中使用，利用合成植入物从内部封闭静脉或动脉。

其他现有解决方案会留下胶原蛋白、缝合线或金属植入物等材料，而 Vivasure 的合成植入物可使动脉或静脉恢复正常状态，不会留下任何残留物。因此，主要企业的战略有助于推动市场增长。

昂贵的血管手术费用将阻碍市场增长

由于血管手术费用昂贵，患者即使需要也无力承担。例如，印度血管手术的平均费用为 600 美元至 800 美元不等，未经处理的自体心包的单位补片费用为 5 美元，而同种移植分支补片的单位补片费用为 6105 美元。因此，血管手术的高成本会阻碍市场增长。

COVID-19 影响分析

COVID-19 流行病对血管补片市场产生了重大影响，给许多国家带来了前所未有的挑战。由于 COVID-19，外科手术急剧减少，手术被推迟。由于手术减少，血管贴片的使用也随之减少。因此，这对血管贴片市场产生了负面影响。

俄乌战争影响分析

据估计，俄乌冲突对全球血管贴片市场的影响不大，因为该地区的主要市场参与者较少。不过，在预测期内，原材料进出口对全球血管贴片市场增长的影响预计不大。

目 录

第 1 章：研究方法与范围

  • 研究方法
  • 报告的研究目标和范围

第2章：定义和概述

第 3 章：执行摘要

  • 按材料类型分類的片段
  • 按应用划分
  • 按最终用户划分
  • 按地区划分

第四章：动态

  • 影响因素
    • 驱动因素
      • 血管疾病发病率上升
      • 老龄人口数量增加
    • 制约因素
      • 缺乏技术人才
    • 机会
      • 治疗方法的发展
    • 影响分析

第 5 章：行业分析

  • 波特五力分析
  • 供应链分析
  • 未满足的需求
  • 监管分析

第 6 章：COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情况
    • COVID-19 期间的情景
    • COVID-19 后的情况
  • COVID-19 期间的定价动态
  • 供求关系
  • 大流行期间与市场相关的政府倡议
  • 制造商的战略倡议
  • 结论

第 7 章 ：俄乌战争分析

第8章：按材料类型划分

  • 自体静脉
  • 牛心包
  • 合成材料
    • 聚四氟乙烯（PTFE）
    • 达克龙

第 9 章：按应用分类

  • 颈动脉内膜切除术
  • 血管搭桥手术
  • 其他

第 10 章：按最终用户分类

  • 医院
  • 门诊手术中心
  • 其他

第 11 章：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第 12 章 ：竞争格局

  • 竞争格局
  • 市场份额分析
  • 合併与收购分析

第 13 章 ：公司简介

  • Becton Dickinson and Company
    • 公司概况
    • 产品组合和说明
    • 财务概况
    • 主要发展
  • Terumo Corporation
  • C R Bard, Inc
  • B Braun MelsungenAG
  • LeMaitre Vascular, Inc
  • Admedus, CryoLife, Inc
  • Labcor Laboratorios Ltd
  • Baxter International IncScience.
  • W.L. Gore&Associates, Inc
  • Vascudyne, Inc.

第 14 章：附录

简介目录
Product Code: MD1408

Market Overview

Global Vascular System Market reached US$ 0.7 billion in 2022 and is expected to reach US$ 1.2 billion by 2030 growing with a CAGR of 7.6% during the forecast period 2023-2030. Factors such as the prevalence of diseases like aneurysms, arterial stenosis, and unwanted blood clots drives the market size in the forecast period. Due to the rise in the number of the aging population, the market is increasing in the North American region with significant competitors like Terumo Corporation, C R Bard Inc, B Braun Melsungen AG, and others.

Vascular patches are used for peripheral vascular reconstruction, surface line buttressing, and other repairs. The patches are also used for femoral, renal, and iliac endarterectomy procedures. vascular patches are made up of polyester urethane. The elastic material used in patches helps to reduce suture hole bleeding.

Market Dynamics

Rising Chronic Venous Insufficiency Will Drive the Market Growth

The major factor that is driving the vascular patches market is the increase in the number of chronic venous insufficiency cases. A number of people are suffering from chronic venous insufficiency, which is leading to vascular surgeries, and that is driving the growth of the market. Rising chronic venous insufficiency will drive market growth, for instance, an article published in Stats Pearls stated that Chronic venous insufficiency (CVI) typically refers to lower extremity edema, skin trophic changes, and discomfort secondary to venous hypertension. Chronic venous insufficiency is a prevalent disease.

Disability related to chronic venous insufficiency attributes to diminished quality of life and loss of work productivity. In most cases, the cause is incompetent valves. Each year approximately 150,000 new patients are diagnosed with chronic venous insufficiency, and nearly $500 million is used in the care of these patients. Thus the rise of diseases will drive the market growth.

Key Strategies by the Key Players will Drive the Market Growth

The rise of key strategies by the key players will dominate the market growth. For instance, on May 19, 2022, in a series of investments, Ireland-based vessel closure device firm Vivasure raised about $25 million to advance clinical development and regulatory approval for its absorbable, patch-based, percutaneous vessel-sealing technology. Utilized during endovascular and cardiovascular procedures, the "PerQseal" technology uses a synthetic implant to seal a vein or artery from the inside.

While other existing solutions leave behind materials such as collagen, sutures, or metal implants, Vivasure's synthetic implants were designed to return an artery or vein to its normal state without leaving any remnants behind. Thus the strategies of the key players help to drive the market growth.

Expensive Cost of Vascular Procedures will Hamper the Market Growth

Due to the expensive cost of vascular procedures, patients could not afford them even if required. For instance, the average cost of vascular surgery in India ranges from US$600-US$800, and the cost per unit patch ranges from $5 (dollars, US) for untreated autologous pericardium to $6,105 for homograft branch patch. Thus high cost of vascular procedures can hamper the market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic epidemic has had a significant influence on the vascular patches market, posing unprecedented challenges to many countries. Due to COVID-19, there is a rapid decrease in surgical procedures, and the surgeries have been postponed. Due to the reduction insurgeries, the usage of vascular patches has been reduced. Thus, it has negatively impacted the vascular patch market.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global vascular patches market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global vascular patches market growth over the forecast period.

Segment Analysis

The global vascular patches market is segmented based on material type, application, and end user.

The Carotid Endarterectomy Segment Holds the Dominant Position in the Market Over Forecast Period with 56.4% share.

Carotid Endarterectomyholds the most significant market share.Carotid endarterectomy is a surgical procedure to remove a build-up of fatty deposits (plaque), which cause the narrowing of a carotid artery. The carotid arteries are the main blood vessels that supply blood to the neck, face, and brain.

Carotid endarterectomy (CEA) is among the most frequently performed vascular operations in the United States. For instance, according to the Journal of Vascular Surgeries, more than 100,000 such operations are performed annually at a cost of $1.2 billion. Thus increase in the number of carotid endarterectomy surgeries is holding the carotid endarterectomy in the top position.

Geographical Analysis

Asia Pacific Accounted for 23.7% of the Market Share Owing to the Prevalence of Diseases

Due to the increasing penetration of commercial providers in this region and the expanding launch of plans by central and state governments. Furthermore, the rising frequency of chronic diseases and densely populated nations such as China and India would drive market expansion in the vascular patches market.

Cardiovascular diseases (CVDs), the world's leading cause of death, claim as many as 17.9 million lives each year globally. According to a study by the Indian Council of Medical Research and Registrar General of India, India accounts for approximately 60 percent of the world's heart disease burden.

Competitive Landscape

The major global players in the global vascular patches market include: Becton, Dickinson and Company; Terumo Corporation; C R Bard, Inc; B Braun MelsungenAG; LeMaitre Vascular, Inc; Admedus; CryoLife, Inc; LabcorLaboratorios Ltd; Baxter International IncScience among others.

Why Purchase the Report?

  • To visualize the global vascular patches market segmentation based on material type, application, end-user, and region,as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global vascular patches market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global vascular patches market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Material Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rise in the prevalence of vascular diseases
      • 4.1.1.2. An increase in the number of elderly aging people
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of skilled individuals
    • 4.1.3. Opportunity
      • 4.1.3.1. Developments in the treatment methods
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario before COVID-19
    • 6.1.2. Scenario during COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. By Material Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material type
    • 8.1.2. Market Attractiveness Index, By Material Type
  • 8.2. Autologous vein
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Bovine pericardium
  • 8.4. Synthetic
    • 8.4.1. Polytetrafluoroethylene (PTFE)
    • 8.4.2. Dacron

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Carotid endarterectomy
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Vascular bypass surgery
  • 9.4. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Ambulatory Surgical Centers
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.6.1. The U.S.
      • 11.2.6.2. Canada
      • 11.2.6.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.6.1. Germany
      • 11.3.6.2. The U.K.
      • 11.3.6.3. France
      • 11.3.6.4. Italy
      • 11.3.6.5. Spain
      • 11.3.6.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.6.1. Brazil
      • 11.4.6.2. Argentina
      • 11.4.6.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.6.1. China
      • 11.5.6.2. India
      • 11.5.6.3. Japan
      • 11.5.6.4. Australia
      • 11.5.6.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Becton Dickinson and Company
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Terumo Corporation
  • 13.3. C R Bard, Inc
  • 13.4. B Braun MelsungenAG
  • 13.5. LeMaitre Vascular, Inc
  • 13.6. Admedus, CryoLife, Inc
  • 13.7. Labcor Laboratorios Ltd
  • 13.8. Baxter International IncScience.
  • 13.9. W.L. Gore&Associates, Inc
  • 13.10. Vascudyne, Inc.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us